Wenzheng Z. Fang
Fuzhou, 350004, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 25 publications
Correction: Qingjie Fuzheng granules attenuate cancer cachexia by restoring gut microbiota homeostasis and suppressing IL-6/NF-κB signaling in colorectal adenocarcinoma.
Journal: Hereditas
Published: September 17, 2025
Qingxie Fuzheng granules attenuate cancer cachexia by restoring gut microbiota homeostasis and suppressing IL-6/NF-κB signaling in colorectal adenocarcinoma.
Journal: Hereditas
Published: July 18, 2025
Synergistic Strategies in Systemic Therapy for Advanced Hepatocellular Carcinoma.
Journal: Global challenges (Hoboken, NJ)
Published: May 12, 2025
Overcoming immune resistance in advanced esophageal squamous cell carcinoma with recombinant human adenovirus type 5 by impacting the immune microenvironment: a case report.
Journal: Frontiers in immunology
Published: April 11, 2025
Baicalin Inhibits Lung Cancer Cell Proliferation and Migration via ALOX12-Mediated Ferroptosis.
Journal: Anti-cancer agents in medicinal chemistry
Published: November 19, 2024
NANS suppresses NF-κB signaling to promote ferroptosis by perturbing iron homeostasis.
Journal: Cell reports
Published: September 12, 2024
Ensartinib rapidly relieves symptoms in ALK-positive patients with brain metastases.
Journal: Asian journal of surgery
Published: March 12, 2024
Development and validation of serological dynamic risk score to predict outcome in gastric cancer with adjuvant chemotherapy: a multicentre, longitudinal, cohort study.
Journal: Frontiers in oncology
Published: November 01, 2023
Toripalimab in combination with Anlotinib for unresectable hepatocellular carcinoma after SBRT: A prospective, single-arm, single-center clinical study.
Journal: Frontiers in oncology
Published: December 01, 2022
The effectiveness and safety of the rapid titration strategy of background controlled-release oxycodone hydrochloride for patients with moderate-to-severe cancer pain: A retrospective cohort study.
Journal: Frontiers in medicine
Published: April 12, 2022
Arterial chemoembolization for patients with hepatocellular carcinoma and elevated lactate dehydrogenase is associated with low survival: a cohort study.
Journal: Infectious agents and cancer
Published: February 24, 2022
Phase 2 randomized controlled trial of intravenous or intraperitoneal paclitaxel plus mFOLFOX6 vs. mFOLFOX6 as first-line treatment of advanced gastric cancer.
Journal: Frontiers in oncology
Published: January 07, 2022
Last Updated: 09/26/2026